BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1469452)

  • 1. HLA-DR2 negative narcolepsy in Australian Caucasians: clinical features, serology and sequence specific oligonucleotide typing.
    Reutens DC; Haddad AP; Cantwell L; Berkovic SF
    J Neurol Sci; 1992 Nov; 113(1):26-30. PubMed ID: 1469452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DQB1-0602 (DQw1) is not present in most nonDR2 Caucasian narcoleptics.
    Mignot E; Lin X; Kalil J; George C; Singh S; Billiard M; Montplaisir J; Arrigoni J; Guilleminault C; Dement WC
    Sleep; 1992 Oct; 15(5):415-22. PubMed ID: 1455124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of HLA-DR2,DQw1 haplotypes in Asian Indians.
    Singal DP; D'Souza M; Sood SK
    Tissue Antigens; 1990 Oct; 36(4):164-70. PubMed ID: 2077672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of HLA-DR2, DQw1 negative post-traumatic narcolepsy].
    Maeda M; Tamaoka A; Hayashi A; Mizusawa H; Shoji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):811-3. PubMed ID: 8777810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing complexity of HLA-DR2 as detected by serology and oligonucleotide typing.
    Schreuder GM; van den Berg-Loonen PM; Verduyn W; Geraets DP; Parlevliet J; van Rood JJ; Giphart MJ
    Hum Immunol; 1991 Oct; 32(2):141-9. PubMed ID: 1683866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narcolepsy-cataplexy in Israeli Jews is associated exclusively with the HLA DR2 haplotype. A study at the serological and genomic level.
    Wilner A; Steinman L; Lavie P; Peled R; Friedmann A; Brautbar C
    Hum Immunol; 1988 Jan; 21(1):15-22. PubMed ID: 2896649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics.
    Matsuki K; Juji T; Tokunaga K; Naohara T; Satake M; Honda Y
    J Clin Invest; 1985 Dec; 76(6):2078-83. PubMed ID: 3865934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy.
    Mignot E; Kimura A; Lattermann A; Lin X; Yasunaga S; Mueller-Eckhardt G; Rattazzi C; Lin L; Guilleminault C; Grumet FC; Mayer G; Dement WC; Underhill P
    Tissue Antigens; 1997 Apr; 49(4):329-41. PubMed ID: 9151385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligonucleotide-genotyping as a method of detecting the HLA-DR2 (DRw15)-Dw2, -DR2 (DRw15)-Dw12, -DR4-Dw15, and -DR4-D"KT2" haplotypes in the Japanese population.
    Obata F; Ito I; Kaneko T; Ohkubo M; Ishimoto AL; Abe A; Kashiwagi N
    Tissue Antigens; 1989 May; 33(5):550-8. PubMed ID: 2799805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA antigens in narcolepsy.
    Neely S; Rosenberg R; Spire JP; Antel J; Arnason BG
    Neurology; 1987 Dec; 37(12):1858-60. PubMed ID: 3683876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The narcolepsy-associated DRw15,DQw6,Dw2 haplotype has no unique HLA-DQA or -DQB restriction fragments and does not extend to the HLA-DP subregion.
    Olerup O; Schaffer M; Hillert J; Sachs C
    Immunogenetics; 1990; 32(1):41-4. PubMed ID: 1973684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No male segregation distortion of DR2 haplotypes in Japanese narcoleptic patients.
    Matsuki K; Juji T; Honda Y
    Hum Immunol; 1988 Sep; 23(1):23-6. PubMed ID: 3263961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HLA and narcolepsy. Apropos of 28 cases including 2 negative HLA-DR2].
    Confavreux C; Gebuhrer L; Betuel H; Freidel C; Bastuji H; Jouvet M; Aimard G; Devic M
    Rev Neurol (Paris); 1988; 144(5):327-31. PubMed ID: 3262232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of HLA-DR2-associated polymorphisms by oligonucleotide hybridization in an Asian Indian population.
    Mehra NK; Verduijn W; Taneja V; Drabbels J; Singh SP; Giphart MJ
    Hum Immunol; 1991 Dec; 32(4):246-53. PubMed ID: 1783571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA restriction fragment length polymorphism of HLA-DR2 haplotypes in normal individuals and in patients with rheumatoid arthritis.
    Singal DP; Reid B; Green D; Bensen WG; D'Souza M
    Ann Rheum Dis; 1990 Mar; 49(3):143-6. PubMed ID: 1969727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA DR2 and DQ1 frequency among narcoleptic patients in Hong Kong Chinese.
    Wing YK; Chen CN; Ho CK
    Psychiatry Clin Neurosci; 1998 Oct; 52(5):523-7. PubMed ID: 10215015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narcolepsy and HLA in the Japanese.
    Juji T; Matsuki K; Tokunaga K; Naohara T; Honda Y
    Ann N Y Acad Sci; 1988; 540():106-14. PubMed ID: 2905117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the occurrence of HLA DR2 in 124 narcoleptics: clinical aspects.
    Roth B; Nevsímalová S; Sonka K; Docekal P; Schulz H; Geisler P; Pollmächer T; Andreas-Zietz A; Keller E; Scholz S
    Schweiz Arch Neurol Psychiatr (1985); 1988; 139(4):41-51. PubMed ID: 2459761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA typing for class II HLA antigens with allele-specific or group-specific amplification. IV. Typing for alleles of the HLA-DR2 group.
    Moraes ME; Fernandez-Viña M; Stastny P
    Hum Immunol; 1991 Jun; 31(2):139-44. PubMed ID: 2066273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR2 and narcolepsy.
    Kramer RE; Dinner DS; Braun WE; Zachary AA; Teresi GA
    Arch Neurol; 1987 Aug; 44(8):853-5. PubMed ID: 3498470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.